Skip to main content
SpringerLink
Log in

Antiviral Action of 2-(α-Hydroxybenzyl)-Benzimidazole (HBB)

  • Chapter
Book cover Targets for the Design of Antiviral Agents

Part of the book series: NATO ASI Series ((NSSA,volume 73))

  • 115 Accesses

Abstract

Since 1952 the antiviral activity of benzimidazoles has been studied extensively (1). A major stimulus during this work has been the central finding that virus-inhibiting activity and cell toxicity of chemical derivatives of benzimidazoles may vary independently (2). The introduction of 2-(α-hydroxybenzyl)-benzimidazole (HBB) as an antiviral agent marked a most important step of the investigations on selective inhibition of viral replication (3,4). It was found that HBB inhibits multiplication of poliovirus 2 in monkey kidney cell culture at concentrations which caused no microscopic changes in the cells. On the other hand, influenza virus multiplication remained unaffected (4).

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 39.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. I. Tamm, K. Folkers, and F. L. Horsfall, Jr., Inhibition of influenza virus multiplication by 2,5-dimethylbenzimidazole. Yale J. Biol. Med. 24: 559 (1952).

    PubMed  CAS  Google Scholar 

  2. I. Tama, Selective inhibition of virus multiplication by synthetic chemicals. Bull. N.Y. Acad. Med., 31: 537 (1955).

    Google Scholar 

  3. A. C. Hollinshead, and P. K. Smith, Effects of certain purines and related compounds on virus propagation. J. Pharmacol. Exp. Ther. 123: 54 (1958).

    PubMed  CAS  Google Scholar 

  4. I. Tamm, and M. M. Nemes, Selective inhibition of poliovirus multiplication. J. Clin. Invest. 38: 1047 (1959).

    Google Scholar 

  5. H. J. Eggers, and I. Tamm, Spectrum and characteristics of the virus inhibitory action of 2-(a-hydroxybenzyl)-benzimidazole. J. Exp. Med. 113: 657 (1961).

    Article  PubMed  CAS  Google Scholar 

  6. H. J. Eggers, and I. Tamm, 2-(a-Hydroxybenzyl)benzimidazole (HBB) as an aid in virus classification. Virology 13: 545 (1961).

    Article  PubMed  CAS  Google Scholar 

  7. I. Tamm, and L. A. Caliguiri, 2-(a-Hydroxybenzyl)benzimidazole and related compounds, in: The International Encyclopedia of Pharmacology and Therapeutics, vol. 1, D. J. Bauer, ed., Pergamon, Oxford, New York, pp. 115 (1972).

    Google Scholar 

  8. H. J. Eggers, Benzimidazoles. Selective inhibitors of picornavirus replication in cell culture and in the organism, in: Chemotherapy of Viral Infections, P. E. Came, and L. A. Caliguiri, eds., Handb. Exp. Pharm., Vol. 61. Springer, Berlin, Heidelberg, New York, pp. 377 (1982).

    Google Scholar 

  9. G. Siegl, and H. J. Eggers, Failure of guanidine and 2-(a-hydroxybenzyl)-benzimidazole to inhibit replication of hepatitis A virus in vitro, J. Gen. Virol. 61: 111 (1982).

    Article  PubMed  CAS  Google Scholar 

  10. H. J. Eggers, and I. Tamm, On the mechanism of selective inhibition of enterovirus multiplication by 2-(a-hydroxybenzyl)-benzimidazole. Virology 18: 426 (1962).

    Article  CAS  Google Scholar 

  11. I. Tamm, R. Bablanian, M. M. Nemes, C. H. Shunk, F. M. Robinson, and K. Folkers, Relationship between structure of benzimidazole derivatives and selective virus inhibitory activity, J. Exp. Med. 113: 625 (1961).

    Article  PubMed  CAS  Google Scholar 

  12. I. Tamm, H. J. Eggers, R. Bablanian, A. F. Wagner, and K. Folkers, Structural requirements of selective inhibition of enteroviruses by 2-(a-hydroxybenzyl)benzimidazole and related compounds. Nature 223: 785 (1969).

    Article  PubMed  CAS  Google Scholar 

  13. I. Tamm, and H. J. Eggers, Differences in the selective virus inhibitory action of 2-(a-hydroxybenzyl)-benzimidazole and guanidine HC1, Virology 18: 439 (1962).

    Article  PubMed  CAS  Google Scholar 

  14. H. J. Eggers, E. Reich, and I. Tamm, The drug-requiring phase in the growth of drug-dependent enteroviruses, Proc. Natl. Acad. Sci. USA 50: 183 (1963).

    Article  PubMed  CAS  Google Scholar 

  15. S. Halperen, H. J. Eggers, and I. Tamm, Evidence for uncoupled synthesis of viral RNA and viral capsids, Virology 24: 36 (1964).

    Article  PubMed  CAS  Google Scholar 

  16. L. A. Caliguiri, H. J. Eggers, N. Ikegami, and I. Tamm, A single-cell study of chemial inhibition of enterovirus multiplicaton, Virology 27: 551 (1965).

    Article  PubMed  CAS  Google Scholar 

  17. H. J. Eggers, and E. Weidner, Effect of 2-(a-hydroxybenzyl)-benzimidazole and guanidine on the uncoating of echovirus 12, Nature 27: 952 (1970).

    Article  Google Scholar 

  18. H. J. Eggers, Selective inhibition of uncoating of echovirus 12 by rhodanine, Virology 78: 241 (1977).

    Article  PubMed  CAS  Google Scholar 

  19. S. E. Luria, J. E. Darnell, Jr., D. Baltimore, and A. Campbell, in: General Virology, 3rd ed., J. Wiley and Sons, New York, Santa Barbara, Chichester, Brisbane, Toronto (1978).

    Google Scholar 

  20. H. J. Eggers, and I. Tamm, Inhibition of enterovirus ribonucleic acid synthesis by 2-(0.-hydroxybenzyl)benzimidazole, Nature 197: 1327 (1963).

    Article  CAS  Google Scholar 

  21. D. Baltimore, and R. M. Franklin, Preliminary data on a virus-specific enzyme system responsible for the synthesis of viral RNA, Biochem. Biophys. Res. Commun. 9: 388 (1962).

    Article  PubMed  CAS  Google Scholar 

  22. D. Baltimore, H. J. Eggers, R. M. Franklin, and I. Tamm, Poliovirus-induced RNA polymerase and the effects of virus-specific inhibitors on its production, Proc. Natl. Acad. Sci. USA 49: 843 (1963).

    Article  PubMed  CAS  Google Scholar 

  23. H. J. Eggers, D. Baltimore, and I. Tamm, The relation of protein synthesis to formation of polio-virus RNA polymerase, Virology 21: 281 (1963).

    Article  PubMed  CAS  Google Scholar 

  24. L. A. Caliguiri, and I. Tamm, Action of guanidine on the replication of poliovirus RNA, Virology 35: 408 (1968).

    Article  PubMed  CAS  Google Scholar 

  25. L. A. Caliguiri, and I. Tamm, Distribution and translation of poliovirus RNA in guanidine-treated cells, Virology 36: 223 (1968).

    Article  PubMed  CAS  Google Scholar 

  26. D. R. Tershak, Inhibition of poliovirus polymerase by guanidine in vitro, J. Virol. 41: 313 (1982).

    PubMed  CAS  Google Scholar 

  27. D. R. Tershak, F. H. Yin, and B. D. Korant, Guanidine, in: Chemotherapy of Viral Infections, P.E. Came, and L.A. Caliguiri, eds., Handb. Exp. Pharm., Vol. 61, Springer, Berlin, Heidelberg, New York, pp. 343 (1982).

    Google Scholar 

  28. R. R. Rueckert, T. J. Matthews, O. M. Kew, M. Pallansch, C. McLean, and D. Omilianowski, Synthesis and processing of picornaviral polyprotein, in: Molecular Biology of Picornaviruses, R. Perezz-Bercoff, ed., Plenum, New York, pp. 113 (1979).

    Chapter  Google Scholar 

  29. P. D. Cooper, B. B. Wentworth, and D. McCahon, Guanidine inhibition of poliovirus: a dependence of viral RNA synthesis on the configuration of structural protein, Virology 40: 486 (1970).

    Article  CAS  Google Scholar 

  30. B. D. Korant, Poliovirus coat protein as the site of guanidine action, Virology 81: 17 (1977).

    Article  Google Scholar 

  31. Th. Adrian, B. Rosenwirth, and H. J. Eggers, Isolation and characterization of temperature-sensitive mutants of echovirus 12, Virology 99: 329 (1979).

    Article  PubMed  CAS  Google Scholar 

  32. H. J. Eggers, and I. Tamm, Antiviral chemotherapy, Annu. Rev. Pharmacol. 6: 231 (1966).

    Article  PubMed  CAS  Google Scholar 

  33. I. Tamm, and H. J. Eggers, Unique susceptibility of enteroviruses to inhibition by 2-(a-hydroxybenzyl)benzimidazole and derivatives, in: 2nd International Symposium of Chemotherapy, Part. II, H. P. Kuemmerle, P. Preziosi, and P. Rentchnick, eds., Karger, Basel New York, pp. 88 (1963).

    Google Scholar 

  34. H. J. Eggers, Discussion to: Genetic recombination with Newcastle disease virus, poliovirus, and influenza (by G. K. Hirst). Cold Spring Harbor Symp. Quant. Biol. 27: 309 (1962).

    Google Scholar 

  35. H. J. Eggers, and I. Tamm, A variant of coxsackie A9 virus which requires 2-(0L-hydroxybenzyl)-benzimidazole (HBB) for optimal growth (Abstr.), in: VIIIth Int. Congr. Microbiol. p. 85 (1962).

    Google Scholar 

  36. H. J. Eggers, and I. Tamm, Drug dependence of enteroviruses: variants of coxsackie A9 and ECHO 13 viruses that require 2-(a-hydroxybenzyl)-benzimidazole for growth, Virology 20: 62 (1963).

    Article  Google Scholar 

  37. H. J. Eggers, and I. Tamm, Coxsackie A9 virus: mutation from drug dependence to drug independence, Science 148: 97 (1965).

    Article  PubMed  CAS  Google Scholar 

  38. B. K. Nottay, O. M. Kew, M. H. Hatch, J. T. Heyward, and J. F. Obijeski, Molecular variation of type 1 vaccine-related and wild polioviruses during replication in humans, Virology 108: 405 (1981).

    Article  PubMed  CAS  Google Scholar 

  39. C. E. Cords, and J. J. Holland, Replication of poliovirus RNA induced by heterologous virus, Proc. Natl. Acad. Sci. USA 51: 1080 (1964).

    Article  PubMed  CAS  Google Scholar 

  40. J. J. Holland, and C. E. Cords, Maturation of polio-virus RNA with capsid protein coded by heterologous enteroviruses, Proc. Natl. Acad. Sci. USA 51: 1082 (1964).

    Article  PubMed  CAS  Google Scholar 

  41. E. Wecker, and G. Lederhilger, Curtailment of the latent period by double-infection with polioviruses, Proc. Natl. Acad. Sci. USA 52: 246 (1964).

    Article  PubMed  CAS  Google Scholar 

  42. V. I. Agol, and G. A. Shirman, Interaction of guanidine-sensitive and guanidine-dependent variants of poliovirus in mixedly infected cells, Biochem. Biophys. Res. Commun. 17: 28 (1964).

    Article  Google Scholar 

  43. N. Ikegami, H. J. Eggers, and I. Tamm, Rescue of drug-requiring and drug-inhibited enteroviruses, Proc. Natl. Acad. Sci. USA 52: 1419 (1964).

    Article  PubMed  CAS  Google Scholar 

  44. R. Bablanian, H. J. Eggers, and I. Tamm, Inhibition of enterovirus cytopathic effects by 2-(a-hydroxybenzyl)-benzimidazole, J. Bacteriol. 91: 1289 (1966).

    PubMed  CAS  Google Scholar 

  45. B. Rosenwirth, and H. J. Eggers, Echovirus 12-induced host cell shutoff is prevented by rhodanine, Nature 267: 370 (1977).

    Article  PubMed  CAS  Google Scholar 

  46. B. Rosenwirth, and H. J. Eggers, Structure and replication of echovirus type 12. 2. Viral polypeptides synthesized in the infected cell, Eur. J. Biochem. 92: 61 (1978).

    Article  PubMed  CAS  Google Scholar 

  47. R. Bablanian, H. J. Eggers, and I. Tamm, Studies on the mechanism of poliovirus-induced cell damage. I. The relation between poliovirus-induced metabolic and morphological alterations in cultured cells, Virology 26: 100 (1965).

    Article  PubMed  CAS  Google Scholar 

  48. R. Bablanian, H. J. Eggers, and I. Tamm, Studies on the mechanism of poliovirus-induced cell damge. II. The relation between poliovirus growth and virus-induced morphological changes in the cells, Virology 26: 114 (1965).

    Article  PubMed  CAS  Google Scholar 

  49. S. Dales, H. J. Eggers, I. Tamm, and G. E. Palade, Electron microscopic study of the formation of poliovirus, Virology 26: 379 (1965).

    Article  PubMed  CAS  Google Scholar 

  50. K. Bienz, D. Egger, Y. Rasser, and W. Bossart, Kinetics and location of poliovirus macromolecular synthesis in correlation to virus-induced cytopathology, Virology 100: 390 (1980).

    Article  PubMed  CAS  Google Scholar 

  51. H. J. Eggers, Successful treatment of enterovirusinfected mice by 2-(a-hydroxybenzyl)-benzimidazole and guanidine, J. Exp. bled. 143: 1367 (1976).

    Article  CAS  Google Scholar 

  52. E. C. Herrmann, Jr., J. A. Herrmann, and D. C. DeLong, Comparision of the antiviral effects of substituted benzimidazoles and guanidine in vitro and in vivo, Antiviral Research 1: 301 (1981).

    Article  CAS  Google Scholar 

  53. R. J. Phillpotts, D. C. DeLong, J. Wallace, R. W. Jones, S. E. Reed, and D. A. J. Tyrrell, The activity of enviroxime against rhinovirus infection in man, Lancet I: 1342 (1981).

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Institut für Virologie, Universität zu Köln, Fürst-Pückler-Str. 56, D-5000, Köln 41, Germany

    Hans J. Eggers

Authors
  1. Hans J. Eggers
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Rega Institute for Medical Research, Catholic University of Leuven, Leuven, Belgium

    E. De Clercq

  2. The University of Birmingham, Birmingham, UK

    R. T. Walker

Rights and permissions

Reprints and permissions

Copyright information

© 1984 Springer Science+Business Media New York

About this chapter

Cite this chapter

Eggers, H.J. (1984). Antiviral Action of 2-(α-Hydroxybenzyl)-Benzimidazole (HBB). In: De Clercq, E., Walker, R.T. (eds) Targets for the Design of Antiviral Agents. NATO ASI Series, vol 73. Springer, Boston, MA. https://doi.org/10.1007/978-1-4684-4709-5_8

Download citation

  • DOI: https://doi.org/10.1007/978-1-4684-4709-5_8

  • Publisher Name: Springer, Boston, MA

  • Print ISBN: 978-1-4684-4711-8

  • Online ISBN: 978-1-4684-4709-5

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation